BiOptic has received ISO13485 certification from TÜV SÜD - BiOptic
2023-02-24
BiOptic has received ISO13485 certification from TÜV SÜD, which will be a strong asset for us to explore the international market. Relevant primary quality certification includes ISO 9001, ISO 13485, and EU CE.
Congratulations! BiOptic’s core products have successfully registered and listed in FDA!
2023-02-22
BiOptic has recently registered and listed the core products and related consumables in the USA FDA Class I category. Items including Qsep Series Bio-Fragment Analyzers, Qampmini Thermal Cycler and multiple cartridges ,etc. In the future, the above mentioned core products can be sold as medical equipment in the United States, which will expand our business scope in the US market.
Pittcon is a dynamic, transnational conference and exposition on laboratory science, a venue for presenting the latest advances in analytical research and scientific instrumentation, and a platform for continuing education and science-enhancing opportunity.
Congratulations! BiOptic has won“The 25th Rising Star Award”
2022-11-17
BiOptic has won“The 25th Rising Star Award”, which is awarded by the Ministry of Economic Affairs. We are so honored that BiOptic could stands out from all Bio-industry companies in Taiwan and be the only Bio-company of the 16 winning companies from various industries. The award ceremony was held on the 16th of November, and Dr. Ming-Jhy Hsu, Chief R&D Director, representing BiOptic to receive this award.
